Menghisteab Bairu's most recent trade in Brainstorm Cell Therapeutics, Inc. was a trade of 24,000 Common Stock done . Disclosure was reported to the exchange on Jan. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Brainstorm Cell Therapeuti... | Menghisteab Bairu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 24,000 | 24,000 (0%) | 0% | 0 | Common Stock |